Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Front Endocrinol (Lausanne) ; 12: 679002, 2021.
Article in English | MEDLINE | ID: mdl-34721286

ABSTRACT

Fetus and infants require appropriate thyroid hormone levels and iodine during pregnancy and lactation. Nature endorses the mother to supply thyroid hormones to the fetus and iodine to the lactating infant. Genetic variations on thyroid proteins that cause dyshormonogenic congenital hypothyroidism could in pregnant and breastfeeding women impair the delivery of thyroid hormones and iodine to the offspring. The review discusses maternal genetic variations in thyroid proteins that, in the context of pregnancy and/or breastfeeding, could trigger thyroid hormone deficiency or iodide transport defect that will affect the proper development of the offspring.


Subject(s)
Congenital Hypothyroidism/genetics , Mutation , Thyroxine/genetics , Triiodothyronine/genetics , Breast Feeding , Female , Humans , Pregnancy
2.
Nat Rev Endocrinol ; 15(6): 323-338, 2019 06.
Article in English | MEDLINE | ID: mdl-30886364

ABSTRACT

In humans, the thyroid hormones T3 and T4 are synthesized in the thyroid gland in a process that crucially involves the iodoglycoprotein thyroglobulin. The overall structure of thyroglobulin is conserved in all vertebrates. Upon thyroglobulin delivery from thyrocytes to the follicular lumen of the thyroid gland via the secretory pathway, multiple tyrosine residues can become iodinated to form mono-iodotyrosine (MIT) and/or di-iodotyrosine (DIT); however, selective tyrosine residues lead to preferential formation of T4 and T3 at distinct sites. T4 formation involves oxidative coupling between two DIT side chains, and de novo T3 formation involves coupling between an MIT donor and a DIT acceptor. Thyroid hormone synthesis is stimulated by TSH activating its receptor (TSHR), which upregulates the activity of many thyroid gene products involved in hormonogenesis. Additionally, TSH regulates post-translational changes in thyroglobulin that selectively enhance its capacity for T3 formation - this process is important in iodide deficiency and in Graves disease. 167 different mutations, many of which are newly discovered, are now known to exist in TG (encoding human thyroglobulin) that can lead to defective thyroid hormone synthesis, resulting in congenital hypothyroidism.


Subject(s)
Thyroglobulin/physiology , Thyroid Gland/metabolism , Thyroxine/biosynthesis , Triiodothyronine/biosynthesis , Animals , Graves Disease/diagnosis , Graves Disease/genetics , Graves Disease/metabolism , Humans , Thyroid Gland/pathology , Thyroid Hormones/biosynthesis , Thyroid Hormones/genetics , Thyroxine/genetics , Triiodothyronine/genetics
3.
J Clin Invest ; 120(6): 2206-17, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20458138

ABSTRACT

Hypothyroidism in humans is characterized by severe neurological consequences that are often irreversible, highlighting the critical role of thyroid hormone (TH) in the brain. Despite this, not much is known about the signaling pathways that control TH action in the brain. What is known is that the prohormone thyroxine (T4) is converted to the active hormone triiodothyronine (T3) by type 2 deiodinase (D2) and that this occurs in astrocytes, while TH receptors and type 3 deiodinase (D3), which inactivates T3, are found in adjacent neurons. Here, we modeled TH action in the brain using an in vitro coculture system of D2-expressing H4 human glioma cells and D3-expressing SK-N-AS human neuroblastoma cells. We found that glial cell D2 activity resulted in increased T3 production, which acted in a paracrine fashion to induce T3-responsive genes, including ectonucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2), in the cocultured neurons. D3 activity in the neurons modulated these effects. Furthermore, this paracrine pathway was regulated by signals such as hypoxia, hedgehog signaling, and LPS-induced inflammation, as evidenced both in the in vitro coculture system and in in vivo rat models of brain ischemia and mouse models of inflammation. This study therefore presents what we believe to be the first direct evidence for a paracrine loop linking glial D2 activity to TH receptors in neurons, thereby identifying deiodinases as potential control points for the regulation of TH signaling in the brain during health and disease.


Subject(s)
Brain/metabolism , Neuroglia/metabolism , Neurons/metabolism , Rodentia/metabolism , Triiodothyronine/metabolism , Animals , Astrocytes/metabolism , Cells/metabolism , Gene Expression , Humans , Hypothyroidism/genetics , Hypothyroidism/metabolism , Iodide Peroxidase/genetics , Iodide Peroxidase/metabolism , Iodide Peroxidase/physiology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Rats , Rats, Sprague-Dawley , Receptors, Thyroid Hormone/genetics , Receptors, Thyroid Hormone/metabolism , Rodentia/genetics , Thyroid Hormones/genetics , Thyroid Hormones/metabolism , Thyroid Hormones/physiology , Thyroxine/genetics , Thyroxine/metabolism , Triiodothyronine/genetics
4.
J Pediatr ; 139(6): 887-91, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11743520

ABSTRACT

We found familial dysalbuminemic hyperthyroxinemia (FDH) in a 5-month-old boy with congenital hypothyroidism (CH) who had a blood thyrotropin (TSH) level of 479 mU/L but normal total serum thyroxine (T4) and higher than normal total triiodothyronine (T3) levels. Thyroid hormone substitution began at 5 weeks of age when T4 and T3 concentrations were below normal. Until the age of 5 months, treatment with levothyroxine was suboptimal on the basis of high serum TSH levels despite above-normal T4 levels. FDH was confirmed by isoelectric focusing and testing of other family members. DNA analysis of the patient revealed R218H, a mutation in the serum albumin gene associated with FDH, which was also present in the patient's euthyroid father and brother. Thyroid scans, serum thyroglobulin measurements, and free T4 measurements using equilibrium dialysis or 2-step immunoassay methods can identify thyroid hormone-binding protein defects and simplify the diagnosis and treatment of infants with CH.


Subject(s)
Albumins/genetics , Albuminuria/genetics , Congenital Hypothyroidism , Hyperthyroxinemia/genetics , Hypothyroidism/genetics , Mutation/genetics , Albuminuria/blood , Humans , Hyperthyroxinemia/blood , Hypothyroidism/blood , Infant , Male , Thyrotropin/blood , Thyrotropin/genetics , Thyroxine/blood , Thyroxine/genetics
SELECTION OF CITATIONS
SEARCH DETAIL